surfactin peptide has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Liu, D; Qi, G; Xing, X; Zhao, X | 1 |
| Gao, Z; Qi, G; Zhang, L; Zhao, X | 1 |
| Ding, J; Qi, G; Xing, X; Zhang, L; Zhao, X | 1 |
3 other study(ies) available for surfactin peptide and Alloxan Diabetes
| Article | Year |
|---|---|
Enteric-coated insulin microparticles delivered by lipopeptides of iturin and surfactin.
Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin; Intestinal Mucosa; Lipopeptides; Mice, Inbred BALB C; Peptides, Cyclic | 2018 |
A natural lipopeptide of surfactin for oral delivery of insulin.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Dogs; Hypoglycemic Agents; Insulin; Lipopeptides; Mice; Peptides, Cyclic; Permeability; Polymers | 2016 |
Surfactin variants for intra-intestinal delivery of insulin.
Topics: Administration, Oral; Animals; Bacterial Proteins; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Drug Delivery Systems; Fatty Acids; Insulin; Intestinal Absorption; Intestinal Mucosa; Lipopeptides; Membranes; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Permeability | 2017 |